A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01) A61K 33/14 (2006.01) A61K 33/40 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2554511
The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.
La présente invention a trait à des procédés de traitement d'une maladie neurodégénérative associée aux macrophages telles que la sclérose latérale amyotrophique, la maladie d'Alzheimer, ou la sclérose en plaques chez un sujet par l'administration de chlorite en une quantité efficace pour réduire l'activation de cellules immunitaires sanguines. L'invention a également trait à des procédés pour un suivie de thérapie par l'évaluation de l'activation des cellules immunitaires sanguines avant et après le traitement.
Fetherstonhaugh & Co.
The Regents Of The University Of California
LandOfFree
Chlorite in the treatment of neurodegenerative disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlorite in the treatment of neurodegenerative disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlorite in the treatment of neurodegenerative disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1631280